ArticleOncoTargets and therapy2021

Remarkable Response to Olaparib in a Patient with Combined Hepatocellular-Cholangiocarcinoma Harboring a Biallelic

Yu-Li Su et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.